Research Roundup

Debbie Rigby takes a look at the latest in research news Pandora’s box: Paxlovid, prescribing, pharmacists and pandemic This editorial provides practical guidance on identifying and managing drug interactions with nirmatrelvir/ritonavir (Paxlovid), an oral antiviral reported to reduce COVID-19-related hospital admission or death from any cause by 89% relative to placebo in unvaccinated adults with